E. W. Young, D. A. Goodkin, D. L. Mapes, F. K. Port, M. L. Keen et al., The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study, Kidney Int, vol.57, pp.74-81, 2000.

F. K. Port, R. L. Pisoni, J. L. Bragg-gresham, S. S. Satayathum, E. W. Young et al., DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States, Blood Purif, vol.22, issue.1, pp.175-80, 2004.

, National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, vol.39, issue.2, pp.1-266, 2002.

F. Locatelli, P. Bárány, A. Covic, D. Francisco, A. et al., Kidney disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement, Nephrol Dial Transplant, vol.28, pp.1346-59, 2013.

, Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group: KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int, pp.279-335, 2012.

, Kidney Disease: Improving Global Outcomes (KDIGO) Work Group: 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int, vol.3, issue.1, pp.1-150, 2013.

K. Kalantar-zadeh, D. L. Regidor, C. P. Kovesdy, D. Van-wyck, S. Bunnapradist et al., Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis, Circulation, vol.119, issue.5, pp.671-680, 2009.

R. Saran, J. L. Bragg-gresham, H. C. Rayner, D. A. Goodkin, M. L. Keen et al., Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS, Kidney Int, vol.64, pp.254-62, 2003.

C. Combe, R. L. Pisoni, F. K. Port, E. W. Young, B. Canaud et al., Dialysis Outcomes and Practice Patterns Study: Données sur l'utilisation des cathéters veineux centraux en hémodialyse chronique, Nephrologie, vol.22, pp.379-84, 2001.

R. K. Dhingra, E. W. Young, T. E. Hulbert-shearon, S. F. Leavey, and F. K. Port, Type of vascular access and mortality in U.S. hemodialysis patients, Kidney Int, vol.60, pp.1443-51, 2001.

R. L. Pisoni, E. W. Young, C. Combe, S. F. Leavey, R. N. Greenwood et al., Higher catheter use within facilities is associated with increased mortality and hospitalization. Results from the DOPPS, J Am Soc Nephrol, vol.299, p.12, 2001.

V. Grubbs, H. Wasse, E. Vittinghoff, B. A. Grimes, and K. L. Johansen, Health status as a potential mediator of the association between hemodialysis vascular access and mortality, Nephrol Dial Transplant, vol.29, issue.4, pp.892-900, 2013.

M. Jadoul, N. Lameire, J. L. Bragg-gresham, M. A. Eichleay, R. L. Pisoni et al., DOPPS estimate of patient life years attributable to modifiable haemodialysis practices in Belgium, Acta Clin Belg, vol.62, issue.2, pp.102-112, 2007.

L. Piera, J. M. Cruz, J. L. Braga-gresham, M. A. Eichleay, R. L. Pisoni et al., Estimación, según el estudio DOPPS, de los años de vida de pacientes atribuibles a las prácticas de hemodiálisis modificables en España, Nefrología, vol.27, issue.4, pp.496-504, 2007.

B. Canaud, C. Combe, J. L. Bragg-gresham, M. A. Eichleay, R. L. Pisoni et al., Gain de vie potentiel pour les patients hémodialysés français attribuable aux modifications des pratiques et la mise en conformité avec les cibles recommandées: une estimation permise par l'étude DOPPS, Néphrol Thér, vol.4, issue.4, pp.256-65, 2008.

B. Wikström, S. H. Jacobson, J. Bragg-gresham, M. Eichleay, R. Pisoni et al., Dialysis Outcomes and Practice Patterns Study estimate of patient life-years attributable to modifiable haemodialysis practices in Sweden, Scand J Urol Nephrol, vol.44, issue.2, pp.113-133, 2010.

L. Gesualdo, G. London, M. Turner, C. Lee, K. Macdonald et al., A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study, Intern Emerg Med, vol.8, issue.5, pp.389-99, 2013.

, National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target, Am J Kidney Dis, vol.50, issue.3, pp.471-530, 2007.

F. Locatelli, P. Aljama, B. Canaud, A. Covic, D. Francisco et al., Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT) Study, Nephrol Dial Transplant, vol.25, issue.9, pp.2846-50, 2010.

F. Locatelli, R. L. Pisoni, C. Combe, J. Bommer, V. E. Andreucci et al., Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Nephrol Dial Transplant, vol.19, issue.1, pp.121-153, 2004.

R. L. Pisoni, C. J. Arrington, J. M. Albert, J. Ethier, N. Kimata et al., Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis, Am J Kidney Dis, vol.53, issue.3, pp.475-91, 2009.

E. Registry, Department of Medical Informatics, 2014.

E. Registry, Department of Medical Informatics, 2013.

D. Nierenersatztherapie-in, QuaSi-Niere gGmbH, Bericht über Dialysebehandlung und Nierentransplantation in Deutschland, 2006.

. Registro-italiano-dialisi-e-trapianto, Società Italiana Nefrologia, 2011.

G. London, J. Mann, D. Goldsmith, C. Combe, F. Dellanna et al., Long-term treatment with biosimilar epoetin-? (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study, Clin Nephrol, vol.89, p.109, 2018.

L. Gesualdo, C. Combe, A. Covic, F. Dellana, D. Goldsmith et al., Risk-based individualisation of target Hb in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study), Int Urol Nephrol, vol.47, pp.837-882, 2015.

C. Combe, A. Covic, D. Goldsmith, P. Zaoui, L. Gesualdo et al., DOPPS-identified modifiable practices in haemodialysis (HD) patients in the European MONITOR-CKD5 (2010-12) study compared to DOPPS (2002-2003): significantly better quality of HD with disparities, Nephrol Dial Transplant, vol.28, issue.1, p.244, 2013.

G. A. Kaysen, Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy?: Management of comorbidities in kidney disease in the 21st century: Anemia and bone disease, Kidney Int, vol.64, pp.92-100, 2003.

C. Karamanidou, J. Clatworthy, J. Weinman, and R. Horne, A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease, BMC Nephrol, vol.9, issue.2, pp.1-10, 2008.

M. Tonelli, N. Pannu, and B. Manns, Oral phosphate binders in patients with kidney failure, New Engl J Med, vol.362, issue.14, pp.1312-1336, 2010.

J. B. Cannata-andia and K. J. Martin, The challenge of controlling phosphorus in chronic kidney disease, Nephrol Dial Transplant, vol.31, pp.541-548, 2016.